Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular disease

J Am Coll Cardiol. 1989 Feb;13(2):265-82. doi: 10.1016/0735-1097(89)90498-1.

Abstract

This review summarizes some of the major advances in the investigation of molecular mechanisms underlying both normal and abnormal cardiovascular function. Four major areas are highlighted including cardiac muscle, the blood vessel, atherosclerosis and thrombosis/thrombolysis. The remarkable strides in understanding multifactorial diseases such as atherosclerosis, and the development of innovative new therapies such as the use of thrombolytic agents produced by recombinant deoxyribonucleic acid (DNA) technology, are noted. Moreover, it is concluded that the past decade of basic research has provided a solid framework for improvements in the diagnosis and therapy of other forms of cardiovascular disease as well. An evaluation of current trends in basic cardiovascular research suggests that diagnostic and therapeutic approaches to disease will increasingly target specific molecular processes underlying the pathophysiologic state.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Arteriosclerosis / physiopathology
  • Cardiovascular Diseases / diagnosis*
  • Cardiovascular Diseases / therapy*
  • Coronary Vessels / physiopathology
  • DNA, Recombinant
  • Endothelium, Vascular / physiology
  • Humans
  • Muscle, Smooth, Vascular
  • Muscles / physiopathology
  • Thrombosis / physiopathology

Substances

  • DNA, Recombinant